Lantern Pharma Inc.

Healthcare

NASDAQ:LTRN · NASDAQ Capital Market

Market Cap $47.08M Beta 2.32 P/E (TTM) -2.7

$4.04 -4.67%

-$0.19 today

52W Low $1.11High $5.74

Vol 0.16M · Avg 0.68M

EPS (TTM) -$1.41Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+31.43%

Period High

$5.32

Period Low

$1.12

Latest

$4.04

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

MAIA Biotechnology, Inc.

AMEX:MAIA

$79.04M

LAVA Therapeutics N.V.

LVTX

$45.77M

Elutia Inc.

ELUT

$42.44M

Annovis Bio, Inc.

ANVS

$35.02M

Actinium Pharmaceuticals, Inc.

ATNM

$31.69M

RenovoRx, Inc.

RNXT

$31.41M

Tvardi Therapeutics, Inc.

TVRD

$24.77M

CalciMedica, Inc.

CALC

$13.70M

BioAtla, Inc.

BCAB

$4.87M

Reviva Pharmaceuticals Holdings, Inc.

RVPH

$2.35M

What is the latest LTRN filing?

The latest filing shown is S-1 dated Jun 12, 2026.

How many recent filings does LTRN have?

Intrinsic Alpha currently shows 20 recent filings for LTRN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.